Moving towards causality in attention-deficit hyperactivity disorder: Overview of neural and genetic mechanisms

The Lancet Psychiatry

Volumn 3, Issue 6, 2016, Pages 555-567

  Gallo, Eduardo F ^a   Posner, Jonathan ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; CONNECTOME; COPY NUMBER VARIATION; ENDOPHENOTYPE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION STUDY; GENETIC RISK; GENETIC VARIATION; HUMAN; NERVE CELL NETWORK; NEUROBIOLOGY; NEUROIMAGING; NEUROMODULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SYMPTOMATOLOGY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAUSALITY; GENETICS; PATHOPHYSIOLOGY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAUSALITY; GENETIC VARIATION; HUMANS; NERVE NET; NEUROBIOLOGY;

EID: 84966937411     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(16)00096-1     Document Type: Review

References (167)

1. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007, 164:942-948.
2. Willcutt EG The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012, 9:490-499.
3. Davies W Sex differences in attention deficit hyperactivity disorder: candidate genetic and endocrine mechanisms. Front Neuroendocrinol 2014, 35:331-346.
4. Spencer TJ, Biederman J, Mick E Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 2007, 32:631-642.
5. Klein RG, Mannuzza S, Olazagasti MA, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 2012, 69:1295-1303.
6. Satterfield JH, Faller KJ, Crinella FM, Schell AM, Swanson JM, Homer LD A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry 2007, 46:601-610.
7. Diagnostic and statistical manual of mental disorders: DSM-5 2013, American Psychiatric Association, American Psychiatric Association, Washington, DC.
8. Shaw P, Stringaris A, Nigg J, Leibenluft E Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry 2014, 171:276-293.
9. Posner J, Kass E, Hulvershorn L Using stimulants to treat ADHD-related emotional lability. Curr Psychiatry Rep 2014, 16:478.
10. Barkley RA, Fischer M The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. J Am Acad Child Adolesc Psychiatry 2010, 49:503-513.
11. Tripp G, Wickens JR Neurobiology of ADHD. Neuropharmacology 2009, 57:579-589.
12. Luman M, Oosterlaan J, Sergeant JA The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal. Clin Psychol Rev 2005, 25:183-213.
13. Sonuga-Barke EJS, Sergeant JA, Nigg J, Willcutt E Executive dysfunction and delay aversion in attention deficit hyperactivity disorder: nosologic and diagnostic implications. Child Adolesc Psychiatr Clin N Am 2008, 17:367-384. ix.
14. Banaschewski T, Hollis C, Oosterlaan J, et al. Towards an understanding of unique and shared pathways in the psychopathophysiology of ADHD. Dev Sci 2005, 8:132-140.
15. Antshel KM, Zhang-James Y, Faraone SV The comorbidity of ADHD and autism spectrum disorder. Expert Rev Neurother 2013, 13:1117-1128.
16. Castellanos FX, Tannock R Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002, 3:617-628.
17. Nigg JT, Nikolas M, Mark Knottnerus G, Cavanagh K, Friderici K Confirmation and extension of association of blood lead with attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom domains at population-typical exposure levels. J Child Psychol Psychiatry 2010, 51:58-65.
18. Milberger S, Biederman J, Faraone SV, Jones J Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J Clin Child Psychol 1998, 27:352-358.
19. Banerjee TD, Middleton F, Faraone SV Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007, 96:1269-1274.
20. Ellison-Wright I, Ellison-Wright Z, Bullmore E Structural brain change in attention deficit hyperactivity disorder identified by meta-analysis. BMC Psychiatry 2008, 8:51.
21. Nakao T, Radua C, Rubia K, Mataix-Cols D Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry 2011, 168:1154-1163.
22. Frodl T, Skokauskas N Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand 2012, 125:114-126.
23. Haber SN The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 2003, 26:317-330.
24. Bush G Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol Psychiatry 2011, 69:1160-1167.
25. Sonuga-Barke EJ Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry 2005, 57:1231-1238.
26. Rubia K, Alegria A, Brinson H Imaging the ADHD brain: disorder-specificity, medication effects and clinical translation. Expert Rev Neurother 2014, 14:519-538.
27. Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA 2007, 104:19649-19654.
28. Almeida LG, Ricardo-Garcell J, Prado H, et al. Reduced right frontal cortical thickness in children, adolescents and adults with ADHD and its correlation to clinical variables: a cross-sectional study. J Psychiatr Res 2010, 44:1214-1223.
29. Montes LGA, Alcántara HP, García RBM, De La Torre LB, Acosta DÁ, Duarte MG Brain cortical thickness in ADHD: age, sex, and clinical correlations. J Atten Disord 2012, 17:641-654.
30. Rubia K Neuro-anatomic evidence for the maturational delay hypothesis of ADHD. Proc Natl Acad Sci USA 2007, 104:19663-19664.
31. Insel TR Disruptive insights in psychiatry: transforming a clinical discipline. J Clin Invest 2009, 119:700-705.
32. Mori S, Zhang J Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006, 51:527-539.
33. Biswal B, Yetkin FZ, Haughton VM, Hyde JS Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995, 34:537-541.
34. Posner J, Hellerstein DJ, Gat I, et al. Antidepressants normalize the default mode network in patients with dysthymia. JAMA Psychiatry 2013, 70:373-382.
35. Posner J, Nagel B, Maia T, et al. Abnormal amygdalar activation and connectivity in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2011, 50:828-837. e3.
36. van Ewijk H, Heslenfeld DJ, Zwiers MP, Buitelaar JK, Oosterlaan J Diffusion tensor imaging in attention deficit/hyperactivity disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev 2012, 36:1093-1106.
37. Nagel BJ, Bathula D, Herting M, et al. Altered white matter microstructure in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2011, 50:283-292.
38. Cha J, Fekete T, Siciliano F, et al. Neural correlates of aggression in medication-naive children with ADHD: multivariate analysis of morphometry and tractography. Neuropsychopharmacology 2015, 40:1717-1725.
39. Posner J, Park C, Wang Z Connecting the dots: a review of resting connectivity MRI studies in attention-deficit/hyperactivity disorder. Neuropsychol Rev 2014, 24:3-15.
40. Fair DA, Posner J, Nagel BJ, et al. Atypical default network connectivity in youth with attention-deficit/hyperactivity disorder. Biol Psychiatry 2010, 68:1084-1091.
41. Posner J, Rauh V, Gruber A, Gat I, Wang Z, Peterson BS Dissociable attentional and affective circuits in medication-naïve children with attention-deficit/hyperactivity disorder. Psychiatry Res 2013, 213:24-30.
42. Castellanos FX, Margulies DS, Kelly C, et al. Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2008, 63:332-337.
43. Buckner RL, Andrews-Hanna JR, Schacter DL The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008, 1124:1-38.
44. Raichle ME, Snyder AZ A default mode of brain function: a brief history of an evolving idea. Neuroimage 2007, 37:1083-1090. discussion 1097-99.
45. Sonuga-Barke EJ, Castellanos FX Spontaneous attentional fluctuations in impaired states and pathological conditions: a neurobiological hypothesis. Neurosci Biobehav Rev 2007, 31:977-986.
46. Peterson BS, Potenza MN, Wang Z, et al. An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am J Psychiatry 2009, 166:1286-1294.
47. Qiu MG, Ye Z, Li QY, Liu GJ, Xie B, Wang J Changes of brain structure and function in ADHD children. Brain Topogr 2011, 24:243-252.
48. Sun L, Cao Q, Long X, et al. Abnormal functional connectivity between the anterior cingulate and the default mode network in drug-naïve boys with attention deficit hyperactivity disorder. Psychiatry Res 2012, 201:120-127.
49. Hoekzema E, Carmona S, Ramos-Quiroga JA, et al. An independent components and functional connectivity analysis of resting state fMRI data points to neural network dysregulation in adult ADHD. Hum Brain Mapp 2014, 35:1261-1272.
50. Cole MW, Schneider W The cognitive control network: integrated cortical regions with dissociable functions. Neuroimage 2007, 37:343-360.
51. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA 2005, 102:9673-9678.
52. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL A default mode of brain function. Proc Natl Acad Sci USA 2001, 98:676-682.
53. Grady CL, Protzner AB, Kovacevic N, et al. A multivariate analysis of age-related differences in default mode and task-positive networks across multiple cognitive domains. Cereb Cortex 2010, 20:1432-1447.
54. Sato JR, Hoexter MQ, Castellanos XF, Rohde LA Abnormal brain connectivity patterns in adults with ADHD: a coherence study. PLoS One 2012, 7:e45671.
55. Cao X, Cao Q, Long X, et al. Abnormal resting-state functional connectivity patterns of the putamen in medication-naïve children with attention deficit hyperactivity disorder. Brain Res 2009, 1303:195-206.
56. Costa Dias TG, Wilson VB, Bathula DR, et al. Reward circuit connectivity relates to delay discounting in children with attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol 2013, 23:33-45.
57. Posner J, Siciliano F, Wang Z, Liu J, Sonuga-Barke E, Greenhill L A multimodal MRI study of the hippocampus in medication-naive children with ADHD: what connects ADHD and depression?. Psychiatry Res 2014, 224:112-118.
58. Rubia K, Halari R, Cubillo A, Mohammad A-M, Brammer M, Taylor E Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task. Neuropharmacology 2009, 57:640-652.
59. Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 2013, 70:185-198.
60. Cortese S, Kelly C, Chabernaud C, et al. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry 2012, 169:1038-1055.
61. Plichta MM, Scheres A Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI literature. Neurosci Biobehav Rev 2014, 38:125-134.
62. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1313-1323.
63. Wood AC, Neale MC Twin studies and their implications for molecular genetic studies: endophenotypes integrate quantitative and molecular genetics in ADHD research. J Am Acad Child Adolesc Psychiatry 2010, 49:874-883.
64. Hawi Z, Cummins TD, Tong J, et al. The molecular genetic architecture of attention deficit hyperactivity disorder. Mol Psychiatry 2015, 20:289-297.
65. Geschwind DH, Flint J Genetics and genomics of psychiatric disease. Science 2015, 349:1489-1494.
66. Gizer IR, Ficks C, Waldman ID Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009, 126:51-90.
67. Cook EH, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995, 56:993-998.
68. Boonstra AM, Kooij JJ, Buitelaar JK, et al. An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am J Med Genet B Neuropsychiatr Genet 2008, 147:397-402.
69. Colzato LS, van den Wildenberg WP, Van der Does AJ, Hommel B Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 2010, 170:782-788.
70. Bidwell LC, Willcutt EG, McQueen MB, et al. A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder. Behav Genet 2011, 41:165-174.
71. Paloyelis Y, Asherson P, Mehta MA, Faraone SV, Kuntsi J DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls. Neuropsychopharmacology 2010, 35:2414-2426.
72. LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996, 1:121-124.
73. McCracken JT, Smalley SL, McGough JJ, et al. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 2000, 5:531-536.
74. Kieling C, Roman T, Doyle AE, Hutz MH, Rohde LA Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol Psychiatry 2006, 60:1163-1165.
75. Lionel AC, Crosbie J, Barbosa N, et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med 2011, 3:95ra75.
76. Daly G, Hawi Z, Fitzgerald M, Gill M Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999, 4:192-196.
77. Lowe N, Kirley A, Hawi Z, et al. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 2004, 74:348-356.
78. Manor I, Corbex M, Eisenberg J, et al. Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am J Med Genet B Neuropsychiatr Genet 2004, 127B:73-77.
79. Manor I, Eisenberg J, Tyano S, et al. Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am J Med Genet 2001, 105:91-95.
80. Seeger G, Schloss P, Schmidt MH Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol Psychiatry 2001, 6:235-238.
81. Sonuga-Barke EJ, Kumsta R, Schlotz W, et al. A functional variant of the serotonin transporter gene (SLC6A4) moderates impulsive choice in attention-deficit/hyperactivity disorder boys and siblings. Biol Psychiatry 2011, 70:230-236.
82. Hawi Z, Dring M, Kirley A, et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry 2002, 7:718-725.
83. Smoller JW, Biederman J, Arbeitman L, et al. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry 2006, 59:460-467.
84. van Rooij D, Hoekstra PJ, Mennes M, et al. Distinguishing adolescents with ADHD from their unaffected siblings and healthy comparison subjects by neural activation patterns during response inhibition. Am J Psychiatry 2015, 172:674-683.
85. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol Psychiatry 2002, 7:913-917.
86. Bruno KJ, Freet CS, Twining RC, Egami K, Grigson PS, Hess EJ Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD. Neurobiol Dis 2007, 25:206-216.
87. Lasky-Su J, Neale BM, Franke B, et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1345-1354.
88. Reif A, Jacob CP, Rujescu D, et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 2009, 66:41-50.
89. Franke B, Neale BM, Faraone SV Genome-wide association studies in ADHD. Hum Genet 2009, 126:13-50.
90. de Silva MG, Elliott K, Dahl HH, et al. Disruption of a novel member of a sodium/hydrogen exchanger family and DOCK3 is associated with an attention deficit hyperactivity disorder-like phenotype. J Med Genet 2003, 40:733-740.
91. Markunas CA, Quinn KS, Collins AL, et al. Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families. Psychiatr Genet 2010, 20:73-81.
92. Arcos-Burgos M, Jain M, Acosta MT, et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry 2010, 15:1053-1066.
93. Fallgatter AJ, Ehlis AC, Dresler T, et al. Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD). Eur Neuropsychopharmacol 2013, 23:458-468.
94. Won H, Mah W, Kim E, et al. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice. Nat Med 2011, 17:566-572.
95. Arias-Vásquez A, Altink ME, Rommelse NN, et al. CDH13 is associated with working memory performance in attention deficit/hyperactivity disorder. Genes Brain Behav 2011, 10:844-851.
96. Salatino-Oliveira A, Genro JP, Polanczyk G, et al. Cadherin-13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2015, 168B:162-169.
97. Ogdie MN, Fisher SE, Yang M, et al. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet 2004, 75:661-668.
98. Lu AT, Ogdie MN, Järvelin MR, et al. Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1488-1494.
99. Ehlers CL, Slutske WS, Lind PA, Wilhelmsen KC Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. Twin Res Hum Genet 2007, 10:805-811.
100. López-Moreno JA, Echeverry-Alzate V, Bühler KM The genetic basis of the endocannabinoid system and drug addiction in humans. J Psychopharmacol 2012, 26:133-143.
101. Williams NM, Zaharieva I, Martin A, et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376:1401-1408.
102. Young JW, Crawford N, Kelly JS, et al. Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 2007, 17:145-155.
103. Lesch KP, Timmesfeld N, Renner TJ, et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna) 2008, 115:1573-1585.
104. Neale BM, Medland S, Ripke S, et al. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010, 49:906-920. the IMAGE II Consortium Group.
105. Takeuchi T, Misaki A, Liang SB, et al. Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J Neurochem 2000, 74:1489-1497.
106. Børglum AD, Demontis D, Grove J, et al. Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry 2014, 19:325-333. the GROUP investigators.
107. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427. Schizophrenia Working Group of the Psychiatric Genomics Consortium.
108. Sekar A, Bialas AR, de Rivera H, et al. Schizophrenia risk from complex variation of complement component 4. Nature 2016, 530:177-183. the Schizophrenia Working Group of the Psychiatric Genomics Consortium.
109. Elia J, Gai X, Xie HM, et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010, 15:637-646.
110. Stergiakouli E, Hamshere M, Holmans P, et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 2012, 169:186-194. the deCODE Genetics, and the Psychiatric GWAS Consortium.
111. Martin J, O'Donovan MC, Thapar A, Langley K, Williams N The relative contribution of common and rare genetic variants to ADHD. Transl Psychiatry 2015, 5:e506.
112. Plomin R, Deary IJ Genetics and intelligence differences: five special findings. Mol Psychiatry 2015, 20:98-108.
113. Hamshere ML, Langley K, Martin J, et al. High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry 2013, 170:909-916.
114. Stergiakouli E, Martin J, Hamshere ML, et al. Shared genetic influences between attention-deficit/hyperactivity disorder (ADHD) traits in children and clinical ADHD. J Am Acad Child Adolesc Psychiatry 2015, 54:322-327.
115. Levy F, Hay DA, McStephen M, Wood C, Waldman I Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997, 36:737-744.
116. Krumm N, O'Roak BJ, Shendure J, Eichler EE A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci 2014, 37:95-105.
117. Lyon GJ, Jiang T, Van Wijk R, et al. Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications. Discov Med 2011, 12:41-55.
118. Baroni A, Castellanos FX Neuroanatomic and cognitive abnormalities in attention-deficit/hyperactivity disorder in the era of 'high definition' neuroimaging. Curr Opin Neurobiol 2015, 30:1-8.
119. Kendler KS, Neale MC Endophenotype: a conceptual analysis. Mol Psychiatry 2010, 15:789-797.
120. Kofler MJ, Rapport MD, Sarver DE, et al. Reaction time variability in ADHD: a meta-analytic review of 319 studies. Clin Psychol Rev 2013, 33:795-811.
121. Leech R, Sharp DJ The role of the posterior cingulate cortex in cognition and disease. Brain 2014, 137:12-32.
122. Karalunas SL, Geurts HM, Konrad K, Bender S, Nigg JT Annual research review: Reaction time variability in ADHD and autism spectrum disorders: measurement and mechanisms of a proposed trans-diagnostic phenotype. J Child Psychol Psychiatry 2014, 55:685-710.
123. Crosbie J, Pérusse D, Barr CL, Schachar RJ Validating psychiatric endophenotypes: inhibitory control and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2008, 32:40-55.
124. Durston S, Mulder M, Casey BJ, Ziermans T, van Engeland H Activation in ventral prefrontal cortex is sensitive to genetic vulnerability for attention-deficit hyperactivity disorder. Biol Psychiatry 2006, 60:1062-1070.
125. Kasper LJ, Alderson RM, Hudec KL Moderators of working memory deficits in children with attention-deficit/hyperactivity disorder (ADHD): a meta-analytic review. Clin Psychol Rev 2012, 32:605-617.
126. Martinussen R, Hayden J, Hogg-Johnson S, Tannock R A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2005, 44:377-384.
127. Alderson RM, Kasper LJ, Hudec KL, Patros CH Attention-deficit/hyperactivity disorder (ADHD) and working memory in adults: a meta-analytic review. Neuropsychology 2013, 27:287-302.
128. Rapport MD, Chung K-M, Shore G, Isaacs P A conceptual model of child psychopathology: implications for understanding attention deficit hyperactivity disorder and treatment efficacy. J Clin Child Psychol 2001, 30:48-58.
129. Park S, Holzman PS Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 1992, 49:975-982.
130. Harvey PO, Le Bastard G, Pochon JB, et al. Executive functions and updating of the contents of working memory in unipolar depression. J Psychiatr Res 2004, 38:567-576.
131. Thompson JM, Gray JM, Hughes JH, Watson S, Young AH, Ferrier IN Impaired working memory monitoring in euthymic bipolar patients. Bipolar Disord 2007, 9:478-489.
132. Cuthbert BN, Kozak MJ Constructing constructs for psychopathology: the NIMH research domain criteria. J Abnorm Psychol 2013, 122:928-937.
133. Tye C, McLoughlin G, Kuntsi J, Asherson P Electrophysiological markers of genetic risk for attention deficit hyperactivity disorder. Expert Rev Mol Med 2011, 13:e9.
134. Helps SK, Broyd SJ, James CJ, Karl A, Chen W, Sonuga-Barke EJS Altered spontaneous low frequency brain activity in attention deficit/hyperactivity disorder. Brain Res 2010, 1322:134-143.
135. Okamoto K, Aoki K Development of a strain of spontaneously hypertensive rats. Jpn Circ J 1963, 27:282-293.
136. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1239-1247.
137. Bizot JC, Chenault N, Houzé B, et al. Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats. Psychopharmacology (Berl) 2007, 193:215-223.
138. Russell VA Neurobiology of animal models of attention-deficit hyperactivity disorder. J Neurosci Methods 2007, 161:185-198.
139. Dalley JW, Fryer TD, Brichard L, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
140. Dalley JW, Everitt BJ, Robbins TW Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011, 69:680-694.
141. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612.
142. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
143. Weiss S, Nosten-Bertrand M, McIntosh JM, Giros B, Martres M-P Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacology 2007, 32:2465-2478.
144. Gainetdinov RR, Jones SR, Caron MG Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 1999, 46:303-311.
145. Shaywitz BA, Yager RD, Klopper JH Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 1976, 191:305-308.
146. Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol Psychiatry 2004, 9:718-726.
147. Davids E, Zhang K, Kula NS, Tarazi FI, Baldessarini RJ Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther 2002, 301:1097-1102.
148. Braz BY, Galiñanes GL, Taravini IR, Belforte JE, Murer MG Altered corticostriatal connectivity and exploration/exploitation imbalance emerge as intermediate phenotypes for a neonatal dopamine dysfunction. Neuropsychopharmacology 2015, 40:2576-2587.
149. Luthman J, Fredriksson A, Lewander T, Jonsson G, Archer T Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology (Berl) 1989, 99:550-557.
150. Hess EJ, Jinnah HA, Kozak CA, Wilson MC Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2. J Neurosci 1992, 12:2865-2874.
151. Raber J, Mehta PP, Kreifeldt M, et al. Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J Neurochem 1997, 68:176-186.
152. Menon P, Deane R, Sagare A, et al. Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice. Brain Res 2010, 1317:218-226.
153. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993, 75:1273-1286.
154. Nelson RJ, Demas GE, Huang PL, et al. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 1995, 378:383-386.
155. Gao Y, Heldt SA Lack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice. Behav Neurosci 2015, 129:50-61.
156. Gallo EF, Iadecola C Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase. J Neurosci 2011, 31:6947-6955.
157. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 1991, 88:11285-11289.
158. Mill J Rodent models: utility for candidate gene studies in human attention-deficit hyperactivity disorder (ADHD). J Neurosci Methods 2007, 166:294-305.
159. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010, 167:748-751.
160. Kim H, Ährlund-Richter S, Wang X, Deisseroth K, Carlén M Prefrontal parvalbumin neurons in control of attention. Cell 2016, 164:208-218.
161. Baddeley A Working memory: looking back and looking forward. Nat Rev Neurosci 2003, 4:829-839.
162. Moffitt TE, Houts R, Asherson P, et al. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry 2015, 172:967-977.
163. McKee AG, Loscher JS, O'Sullivan NC, et al. AAV-mediated chronic over-expression of SNAP-25 in adult rat dorsal hippocampus impairs memory-associated synaptic plasticity. J Neurochem 2010, 112:991-1004.
164. Zoratto F, Tringle AL, Bellenchi G, et al. Impulsivity and home-cage activity are decreased by lentivirus-mediated silencing of serotonin transporter in the rat hippocampus. Neurosci Lett 2013, 548:38-43.
165. Hadaczek P, Kohutnicka M, Krauze MT, et al. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther 2006, 17:291-302.
166. Rubia K, Alegria AA, Cubillo AI, Smith AB, Brammer MJ, Radua J Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Biol Psychiatry 2014, 76:616-628.
167. Chen AC, Oathes DJ, Chang C, et al. Causal interactions between fronto-parietal central executive and default-mode networks in humans. Proc Natl Acad Sci USA 2013, 110:19944-19949.